Teriparatide
Teriparatide is an approved active ingredient.
Pharmaceutical drug
What it is used for
- Bone fracture
- Postmenopausal osteoporosis
- Osteoarthritis susceptibility 1
- Bone disease
- Osteoporosis
- Hypoparathyroidism
BONSITY is indicated: For the treatment of postmenopausal women with osteoporosis at high risk for fracture (defined herein as having a history of osteoporotic fracture or multiple risk factors for fracture) or who have failed or are intolerant to other available osteoporosis therapy.
Teriparatide SUN is indicated in adults. Treatment of osteoporosis in postmenopausal women and in men at increased risk of fracture.
How it works
- Parathyroid hormone receptor agonist
Common side effects
The following clinically significant adverse reactions are described elsewhere in the labeling: Hypersensitivity Reactions Osteosarcoma Hypercalcemia and Cutaneous Calcification Risk of Urolithiasis Orthostatic Hypotension Risk of Digoxin Toxicity Most common adverse reactions (>10%) include: arthralgia, pain, and…
Who should not take it
BONSITY is contraindicated in patients with a history of severe hypersensitivity to teriparatide or any of the inactive ingredients of BONSITY. Reactions have included anaphylaxis and angioedema.
Pregnancy and breastfeeding
There are no available data on BONSITY use in pregnant women to evaluate for drug-associated risk of major birth defects, miscarriage, or adverse maternal or fetal outcomes.
Interactions
Brand names
United States
Bonsity
European Union
Forsteo · Kauliv · Livogiva · Movymia · Sondelbay · Teriparatide Sun · Terrosa · Zandoriah
Canada
Apo-Teriparatide · Osnuvo · Teva-Teriparatide
Other trade names
Qutavina
Approval status
- US Food and Drug Administration
- prescription · since 2002
- European Medicines Agency
- authorised · since 2003
- Health Canada
- prescription · marketed
- First approval anywhere
- 2002
Codes
- ATC
- H05AA02
- RxNorm CUI
- 32915
- ChEMBL
- CHEMBL525610
- PubChem CID
- 132274287
- Wikidata
- Q411781
Frequently asked questions
What is Teriparatide used for?
Teriparatide is used for: Bone fracture, Postmenopausal osteoporosis, Osteoarthritis susceptibility 1, Bone disease, Osteoporosis, and Hypoparathyroidism.
What are the brand names of Teriparatide?
Brand names of Teriparatide include Bonsity, Forsteo, Kauliv, Livogiva, Movymia, Sondelbay, Teriparatide Sun, and Terrosa.
Sources and licences
- ChEMBL (CC BY-SA 3.0)
- Wikidata (CC0 1.0)
- openFDA / DailyMed (public domain)
- European Medicines Agency (reuse with acknowledgement)
- Health Canada Drug Product Database (Open Government Licence – Canada)